Literature DB >> 8344360

CD4+8- help prevents rapid deletion of CD8+ cells after a transient response to antigen.

J Kirberg1, L Bruno, H von Boehmer.   

Abstract

We have followed the fate of mature CD8+ T cells with a male-specific transgenic T cell receptor after antigenic stimulation with hemopoietic cells in the absence or presence of help. Our data show that mature CD8+ T cells can be deleted after a 3-week period of transient activation and that help, e.g. in the form of interleukin-2, can considerably delay the deletion. These experiments have implications for the design of protocols aiming at the establishment of specific immunological tolerance in T cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344360     DOI: 10.1002/eji.1830230835

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.

Authors:  Ingunn M Stromnes; Joseph N Blattman; Xiaoxia Tan; Sara Jeevanjee; Hua Gu; Philip D Greenberg
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

2.  T helper lymphocytes rescue CTL from activation-induced cell death.

Authors:  Richard Kennedy; Esteban Celis
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

3.  A two-step, two-signal model for the primary activation of precursor helper T cells.

Authors:  P A Bretscher
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

4.  CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

Authors:  M G von Herrath; M Yokoyama; J Dockter; M B Oldstone; J L Whitton
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

5.  CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes.

Authors:  Rinke Bos; Linda A Sherman
Journal:  Cancer Res       Date:  2010-10-12       Impact factor: 12.701

6.  Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes.

Authors:  U Walter; T Toepfer; K E J Dittmar; K Kretschmer; J Lauber; S Weiss; G Servos; O Lechner; W A Scherbaum; S R Bornstein; H Von Boehmer; J Buer
Journal:  Diabetologia       Date:  2003-07-10       Impact factor: 10.122

7.  CD40 ligand-mediated interactions are involved in the generation of memory CD8(+) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection.

Authors:  P Borrow; D F Tough; D Eto; A Tishon; I S Grewal; J Sprent; R A Flavell; M B Oldstone
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

Review 8.  Developing strategies in the immunotherapy of leukemias.

Authors:  Jason B Brayer; Javier Pinilla-Ibarz
Journal:  Cancer Control       Date:  2013-01       Impact factor: 3.302

9.  Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial.

Authors:  Alessandro D Santin; Stefania Bellone; Michela Palmieri; Alessandro Zanolini; Antonella Ravaggi; Eric R Siegel; Juan J Roman; Sergio Pecorelli; Martin J Cannon
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

10.  Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance.

Authors:  B Rocha; A Grandien; A A Freitas
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.